The following is a post I had written last week in response to British Columbia's top health official announcing that pure ecstasy (MDMA) is "safe."
Call me a prude, but I'm not so thrilled about the announcement made on June 14 by British Columbia's top health official that ecstasy is "safe."
Dr. Perry Kendall asserted that the health risks of 3,4-methylenedioxymethamphetamine—or MDMA, the active ingredient in the drug ecstasy—are exaggerated, and that pure ecstasy is not dangerous when consumed responsibly by adults.
Its lethal dangers arise, he says, when gangs pollute the drug with other chemicals.
I'm not sure when the notion came into play that anything which doesn't kill you automatically means its "safe," but I would like to respectfully debunk Dr. Kendall's remarks with a very powerful and striking study published 13 years ago.
Ecstasy, best known for its recreational use among the "rave" scene, can induce euphoria, diminished anxiety, and a sense of intimacy with others.
Specifically, MDMA induces release of the neurotransmitter serotonin by causing serotonin-containing vesicles to dock and enter the synapse. Higher-than-normal serotonin levels can result in neurotoxicity in the brain.
What, exactly, causes the euphoria from MDMA is not entirely clear; other drugs that release serotonin, such as fenfluramine, do not have this effect.
Remember those old "Just Say No" PSAs from the late '80s championed by First Lady Nancy Reagan? "This is drugs." An egg cracks into a sizzling skillet. "This is your brain on drugs. Any questions?" The commercials were short, memorable, and got the point across, albeit lacking scientific support. Who cares about thescience with such a powerful visual, anyway?
How's this for a scientific visual: in 1999, the Journal of Neuroscience published a study by Johns Hopkins researchers examining the effects of short-term MDMA use on the brain over the long-term. In other words, can a single weekend of hard partying result in deficits years down the road?
Hatzidimitriou and colleagues injected 5 mg/kg MDMA (pure MDMA—just as Dr. Kendall assures is "safe") in squirrel monkeys subcutaneously twice a day for four days. That's about the equivalent of an average 150 lb. person consuming 3 ecstasy tablets per day.
The researchers then examined serotonergic neurons (neurons that release serotonin) in the cortex of the brain over time by staining the cells with an antibody for visualization. The results were astounding:
Two weeks after just four days of ecstasy use, there is a highly significant reduction of serotonergic neurons in the cortex (middle panel) compared to control. Terrifying, right? It gets worse. Just look at the effects after seven years of recovery (right panel)—still a marked reduction in neurons.
Short-term physiological effects of MDMA include increased heart rate, blood pressure, and body temperature; blurred vision; sweating; loss of appetite; nausea; and jaw-clenching. Overdose can cause paranoia, hallucinations, hemorrhage, fainting, and organ failure.
Sure sounds like "ecstasy" lives up to its name, right?
Currently, clinical trials are testing the therapeutic potential for controlled MDMA in anxiety disorders such as post-traumatic stress disorder (PTSD) and the anxiety associated with terminal cancer.
Dr. Kendall's statement comes after a string of 16 death in British Columbia since last July associated with a tainted batch of ecstasy containing the toxin PMMA. The health official wants to explore legalization of the drug, asserting that he is "quite a strong critic of prohibition" in that it doesn't do "much to reduce harmful use" or put "billions of dollars into the hands of criminal enterprises."
On a socio-economic level, he has a point. But...safe? Ecstasy is safe?
Let's make sure citizens are getting the facts before we tell them what they want to hear.
* Note: Ricaurte's research has received criticism for his methodologies. In 2003, four of his studies were revealed to have administered methamphetamine instead of MDMA due to a mislabeled purchase, but the particular experiment I presented here was not among them. I welcome any other comments and insight regarding Ricuarte's MDMA studies.
Hatzidimitriou G, McCann UD, & Ricaurte GA (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. The Journal of neuroscience : the official journal of the Society for Neuroscience, 19 (12), 5096-107 PMID: 10366642